0001735845-18-000001.txt : 20180328 0001735845-18-000001.hdr.sgml : 20180328 20180328114846 ACCESSION NUMBER: 0001735845-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180328 DATE AS OF CHANGE: 20180328 EFFECTIVENESS DATE: 20180328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wallkill BioPharma Inc. CENTRAL INDEX KEY: 0001735845 IRS NUMBER: 823737885 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-308764 FILM NUMBER: 18717506 BUSINESS ADDRESS: STREET 1: 1013 CENTRE ROAD STREET 2: SUITE 403-B CITY: WILMINGTON STATE: DE ZIP: 19805 BUSINESS PHONE: (858) 900-1521 MAIL ADDRESS: STREET 1: 5605 SOUTHERN HILLS COURT CITY: FLOWER MOUND STATE: TX ZIP: 75022 D 1 primary_doc.xml X0708 D LIVE 0001735845 Wallkill BioPharma Inc. 1013 CENTRE ROAD SUITE 403-B WILMINGTON DE DELAWARE 19805 (858) 900-1521 DELAWARE None None Corporation true 2017 GERALD SWISS PO BOX 9916 RANCHO SANTA FE CA CALIFORNIA 92067 Executive Officer Director DIRECTOR AND PRESIDENT MARTIN BELL 315 EAST 68TH STREET APARTMENT 13K NEW YORK NY NEW YORK 10065 Executive Officer Director DIRECTOR, VICE-PRESIDENT, SECRETARY AND TREASURER Biotechnology Decline to Disclose 06b false 2017-10-22 false true false 0 207513 207513 0 false 6 0 0 0 false Wallkill BioPharma Inc. GERALD SWISS GERALD SWISS PRESIDENT 2018-03-28